The SPES_MED project

Research Square 2026 Preprint Open access

Read full text
Authors: Gaia Pupillo, A. Andrighetto, Alberto Arzenton, Michele Ballan, Francesca Barbaro, Nicola Belcari, F. Broggi, Fiorella Maria Cagnetta, L. Canton, Sara Cisternino, Michele Colucci, Giancarlo D’Agostino
+25 more P. Delogu, Lucia De Dominicis, Laura De Nardo, Marco Di Luzio, Antonietta Donzella, Juan Esposito, Lorenzo Gaddi, Andrea Gandini, Flavia Maria Groppi Garlandini, Alisa Kotliarenko, Yuliia Lashko, Aurora Leso, M. Lunardon, Simone Alexandra Manenti, Sandra Moretto, Liliana Mou, Elisa Persico, D. Scarpa, Davide Serafini, Omorjit Singh Khwairakpam, Giancarlo Sportelli, Giulia Valli, Giacomo Voltan, Lisa Zangrando, E. Mariotti
DOI: 10.21203/rs.3.rs-10055208/v1
Cited by: 1

Abstract

Abstract The production of medical radionuclides is one of the research activities carried out in the framework of the SPES (Selective Production of Exotic Species) project under the completion stage at the Legnaro National Laboratories of the National Institute for Nuclear Physics (INFN-LNL). This work outlines the main goals of the “SPES_MED” project, funded for the 2025–2027 years, aiming at research activities to produce medical radionuclides exploiting both the direct activation method and the ISOL technique at SPES. Results obtained during the first year of the project, regarding recent nuclear cross section measurements, ISOL-production and nuclear modelling, will be described.

Fields of Study & Subjects

Radioactive Decay and Measurement Techniques Radiopharmaceutical Chemistry and Applications Nuclear reactor physics and engineering

Publication details

Journal / source
Research Square
Publisher
Springer Science and Business Media LLC
Publication date
8 July 2026
Document type
Preprint